Patanjali Herbal Research Department, Patanajli Research Institute, Haridwar, India.
Curr Pharm Biotechnol. 2021;22(10):1350-1359. doi: 10.2174/1389201021999201110204116.
COVID-19 caused by SARS-CoV-2 has been declared as a global pandemic by WHO. Comprehensive analysis of this unprecedented outbreak may help to fight against the disease and may play a pivotal role in decreasing the mortality rate linked with it. Papain-like protease (PLpro), a multifunctional polyprotein, facilitates the replication of SARS-CoV-2 and evades it from the host immunological response by antagonizing cytokines, interferons and may be considered as a potential drug target to combat the current pandemic.
Natural moieties obtained from medicinal plants were analysed for their potency to target PLpro of SARS-CoV-2 by molecular docking study and were compared with synthetic analogs named as remdesivir, chloroquine and favipiravir. The stability of complexes of top hits was analysed by MD Simulation, and interaction energy was calculated. Furthermore, average RMSD values were computed and deepsite ligand-binding pockets were predicted using Play Molecule. Drug-like-abilities of these moieties were determined using ADMET and bond distance between the ligand and active site was assessed to predict the strength of the interaction.
Nimbocinol (-7.6 Kcal/mol) and sage (-7.3 Kcal/mol) exhibited maximum BA against PLpro SARS-CoV-2 as evident from molecular docking study, which was found to be even better than remdesivir (-6.1 Kcal/mol), chloroquine (-5.3 Kcal/mol) and favipiravir (-5.7 Kcal/mol). Both nimbocinol- PLpro and sage-PLpro SARS-CoV-2 complex exhibited stable conformation during MD Simulation of 101ns at 310 K, and potential, kinetic and electrostatic interaction energies were computed, which was observed to be concordant with results of molecular docking study. RMSD average values were found to be 0.496 ± 0.015 Å and 0.598 ± 0.023 Å for nimbocinol and sage, respectively, thus revealing that both the deviation and fluctuations during MD Simulation were observed to be least. Deepsite prediction disclosed that both compounds occupied cryptic pockets in receptor and non-bond distance analysis revealed the formation of hydrogen bonds during ligand-receptor interaction. ADMET exploration further validated the drug-like properties of these compounds.
Present study revealed that active constituents of Azadirachta indica and Salvia officinalis can be potentially used to target SARS-CoV-2 by hindering its replication process.
由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的 COVID-19 已被世界卫生组织(WHO)宣布为全球大流行。对这一史无前例的疫情进行全面分析,有助于抗击该疾病,并可能在降低相关死亡率方面发挥关键作用。木瓜蛋白酶样蛋白酶(PLpro)是一种多功能的多蛋白,通过拮抗细胞因子和干扰素,促进 SARS-CoV-2 的复制,并逃避宿主的免疫反应,可被视为对抗当前大流行的潜在药物靶点。
通过分子对接研究分析了来源于药用植物的天然分子,以评估它们对 SARS-CoV-2 PLpro 的靶向潜力,并与合成类似物瑞德西韦、氯喹和法匹拉韦进行了比较。通过 MD 模拟分析了前几个命中化合物的复合物的稳定性,并计算了相互作用能。此外,还计算了平均 RMSD 值,并使用 Play Molecule 预测了深结合口袋。使用 ADMET 确定了这些分子的类药性,并评估了配体与活性位点之间的键距离,以预测相互作用的强度。
分子对接研究表明,荜茇酚(-7.6 Kcal/mol)和鼠尾草(-7.3 Kcal/mol)对 SARS-CoV-2 PLpro 的 BA 最大,甚至优于瑞德西韦(-6.1 Kcal/mol)、氯喹(-5.3 Kcal/mol)和法匹拉韦(-5.7 Kcal/mol)。荜茇酚-PLpro SARS-CoV-2 和鼠尾草-PLpro SARS-CoV-2 复合物在 310 K 下的 101ns MD 模拟中均表现出稳定的构象,计算了潜在、动力学和静电相互作用能,这与分子对接研究的结果一致。荜茇酚和鼠尾草的 RMSD 平均值分别为 0.496 ± 0.015 Å 和 0.598 ± 0.023 Å,这表明在 MD 模拟过程中,两者的偏差和波动都最小。DeepSite 预测表明,这两种化合物都占据了受体的隐匿口袋,非键距离分析表明,在配体-受体相互作用过程中形成了氢键。ADMET 研究进一步验证了这些化合物的类药性。
本研究表明,印楝和鼠尾草的活性成分可能通过抑制 SARS-CoV-2 的复制过程,被潜在用于靶向 SARS-CoV-2。